DealsInflexion exits PharmaspectraPharmaspectra's sale is Inflexion’s fourth to a US-listed buyer in the last 12 months.ByDavid Wansboro8 August 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeUKWestern EuropeHealthcareTop Stories